These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 2973378)

  • 1. Cardiogenic shock complicating acute myocardial infarction.
    Gunnar RM
    Circulation; 1988 Dec; 78(6):1508-10. PubMed ID: 2973378
    [No Abstract]   [Full Text] [Related]  

  • 2. [Impact of the intra-aortic balloon pump in the mortality due to cardiogenic shock secondary to acute myocardial infarction].
    Arias EA; González-Chon O; García-López SM; Chacón MA; Noriega-Iriondo F; Vega RE; Chávez-Tapia NC
    Arch Cardiol Mex; 2005; 75(3):260-6. PubMed ID: 16294814
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment options for acute myocardial infarction complicated by cardiogenic shock.
    Dauerman HL; Goldberg RJ; Gore JM
    Cardiol Rev; 2000; 8(4):207-15. PubMed ID: 11174897
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impedance cardiography for aortic balloon counterpulsation impact assessment on patients hemodynamics during acute myocardial infarction.
    Brazdzionyte J; Macas A
    Medicina (Kaunas); 2006; 42(11):904-13. PubMed ID: 17172792
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Cardiogenic shock complicating acute myocardial infarction: trends in management and outcome].
    Grazi M; Farina S; Assanelli E
    Recenti Prog Med; 2010 Mar; 101(3):99-105. PubMed ID: 20461950
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Multidisciplinary approach to the treatment of cardiogenic shock].
    Nadziakiewicz P; Knapik P; Gasior M; Kalarus Z; Poloński L; Zembala M
    Kardiol Pol; 2007 Jan; 65(1):105-9. PubMed ID: 17295171
    [No Abstract]   [Full Text] [Related]  

  • 7. Comparison of hospital mortality with intra-aortic balloon counterpulsation insertion before versus after primary percutaneous coronary intervention for cardiogenic shock complicating acute myocardial infarction.
    Abdel-Wahab M; Saad M; Kynast J; Geist V; Sherif MA; Richardt G; Toelg R
    Am J Cardiol; 2010 Apr; 105(7):967-71. PubMed ID: 20346314
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of intra-aortic balloon counterpulsation in cardiogenic shock complicating acute myocardial infarction. Do we really need more evidence?
    Ohlmann P; Morel O; Kindo M; Radulescu B; Kremer H; Bareiss P
    Crit Care Med; 2010 Jan; 38(1):321-2. PubMed ID: 20023483
    [No Abstract]   [Full Text] [Related]  

  • 9. Heart and kidney: the cardiorenal syndrome in cardiogenic shock.
    Karth GD
    Crit Care Med; 2010 Feb; 38(2):699-700. PubMed ID: 20083931
    [No Abstract]   [Full Text] [Related]  

  • 10. Mechanical versus pharmacologic support for cardiogenic shock.
    Dhar G; Jolly N
    Catheter Cardiovasc Interv; 2010 Mar; 75(4):626-9. PubMed ID: 20049971
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Cardiogenic shock after acute myocardial infarction].
    Janssens U
    Internist (Berl); 2006 Apr; 47(4):383-4, 386-8. PubMed ID: 16496103
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The use of intra-aortic balloon counterpulsation in patients with cardiogenic shock complicating acute myocardial infarction: data from the National Registry of Myocardial Infarction 2.
    Barron HV; Every NR; Parsons LS; Angeja B; Goldberg RJ; Gore JM; Chou TM;
    Am Heart J; 2001 Jun; 141(6):933-9. PubMed ID: 11376306
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Management of acute myocardial infarction with hypotension.
    Noble RJ; Tavel ME
    Chest; 1999 Nov; 116(5):1464-7. PubMed ID: 10559114
    [No Abstract]   [Full Text] [Related]  

  • 14. Intra-aortic balloon counterpulsation in acute myocardial infarction complicated by cardiogenic shock (IABP-SHOCK II): final 12 month results of a randomised, open-label trial.
    Thiele H; Zeymer U; Neumann FJ; Ferenc M; Olbrich HG; Hausleiter J; de Waha A; Richardt G; Hennersdorf M; Empen K; Fuernau G; Desch S; Eitel I; Hambrecht R; Lauer B; Böhm M; Ebelt H; Schneider S; Werdan K; Schuler G;
    Lancet; 2013 Nov; 382(9905):1638-45. PubMed ID: 24011548
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Cardiogenic shock in myocardial infarction: revascularization, mechanical support and pharmacotherapy].
    Buerke M; Russ M; Werdan K
    Dtsch Med Wochenschr; 2008 Nov; 133(48):2516-21. PubMed ID: 19021085
    [No Abstract]   [Full Text] [Related]  

  • 16. [Cardiogenic shock].
    Nuding S; Schröder J; Werdan K
    Dtsch Med Wochenschr; 2014 Dec; 139(49):2513-6. PubMed ID: 25423459
    [No Abstract]   [Full Text] [Related]  

  • 17. Utility of levosimendan, a new calcium sensitizing agent, in the treatment of cardiogenic shock due to myocardial stunning in patients with ST-elevation myocardial infarction: a series of cases.
    García-González MJ; Domínguez-Rodríguez A; Ferrer-Hita JJ
    J Clin Pharmacol; 2005 Jun; 45(6):704-8. PubMed ID: 15901754
    [No Abstract]   [Full Text] [Related]  

  • 18. Usefulness of pre- versus postadmission cardiogenic shock during acute myocardial infarction in predicting survival.
    Barbash IM; Hasdai D; Behar S; Boyko V; Gottlieb S; Ilia R; Battler A; Leor J;
    Am J Cardiol; 2001 May; 87(10):1200-3; A7. PubMed ID: 11356399
    [No Abstract]   [Full Text] [Related]  

  • 19. [Principles, means and potentials for decreasing hospital mortality in acute myocardial infarct].
    Petrov K
    Vutr Boles; 1985; 24(2):36-43. PubMed ID: 3898585
    [No Abstract]   [Full Text] [Related]  

  • 20. [New pharmacological treatment approaches to cardiogenic shock].
    Buerke M; Russ M; Werdan K
    Internist (Berl); 2007 Dec; 48(12):1442-9. PubMed ID: 18034221
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.